Rheuma SPACE - Standard Practice Aiming Clinical Excellence: the first Portuguese Rheumatology Department evaluation.

The Portuguese Rheumatology Society (SPR) embraced quality as a major goal and launched, in early 2015, a program to aim for excellence in global clinical care: Rheuma SPACE - Standard Practice Aiming Clinical Excellence. Evaluating daily reality is the first step in a quality development timeline, ultimately contributing for health gains. Herein we describe the results of the evaluation of the quality indicators defined for this project and the improvement strategies identified. The Rheuma SPACE project included three phases: 1) establishing a set of quality indicators and an excellence quality model; 2) assessment of the current care at Rheumatology departments concerning the defined quality indicators in the scope of the excellence model; and 3) elaboration of global and customized reports for each participating Rheumatology department, resulting in the identification of improvement opportunities. Ten Rheumatology departments, countrywide, including larger and smaller institutions, were asked to participate in Rheuma SPACE. This resulted in an individual report for each department along with global benchmarking practices analysis. Furthermore, a list of improvement initiatives was developed. We concluded that departments lack physicians and need exclusively dedicated nurses. Time dedicated to research and audit activities should be specifically allocated. Internal contracting is well established, and professionals are committed to targets. Processes are still suboptimal, needing standardization of triage criteria, more frequent follow-up, as well as better medical records and multidisciplinary coverage. Regarding outcomes, patients are satisfied with the provided care and professionals with the working environment. However, department facilities for the former, and career related aspects, for the latter should improve. With this innovative study conducted in Portugal we expect to have enlightened tailored opportunities for improvement, ensure patient-focused practices and be able to define the indispensable quality requirements for excellence.

[1]  M. Santos,et al.  Early retirement attributed to rheumatoid arthritis and its predictors. , 2020, Acta reumatologica portuguesa.

[2]  A. Barton,et al.  Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis , 2020, Rheumatology.

[3]  H. Pieringer,et al.  The Supply of Rheumatology Specialist Care in Real Life. Results of a Nationwide Survey and Analysis of Supply and Needs , 2020, Frontiers in Medicine.

[4]  J. Fonseca,et al.  Rheuma SPACE - Standard Practice Aiming Clinical Excellence: description of the methodological approach. , 2019, Acta reumatologica portuguesa.

[5]  Y. van Eijk-Hustings,et al.  2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis , 2019, Annals of the rheumatic diseases.

[6]  E. Badley,et al.  Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada , 2017, The Journal of Rheumatology.

[7]  M. Genovese,et al.  Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures , 2016, Arthritis care & research.

[8]  H. Markel,et al.  Donabedian's Lasting Framework for Health Care Quality. , 2016, The New England journal of medicine.

[9]  C. Bombardier,et al.  Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data. , 2016, CMAJ open.

[10]  R. Moots,et al.  Quality indicators in rheumatoid arthritis: results from the METEOR database. , 2015, Rheumatology.

[11]  S. Castañeda,et al.  Rheumatology in the community of Madrid: current availability of rheumatologists and future needs using a predictive model. , 2013, Reumatologia clinica.

[12]  A. Woolf,et al.  Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project , 2013, Annals of the rheumatic diseases.

[13]  A. Woolf,et al.  Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project , 2013, Annals of the rheumatic diseases.

[14]  S. Muñoz Fernández,et al.  Quality of care standards for nursing clinics in rheumatology. , 2013, Reumatologia clinica.

[15]  L. Carmona,et al.  Quality-of-care standards for early arthritis clinics , 2013, Rheumatology International.

[16]  Tamas Koncz,et al.  Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial , 2013, The Lancet.

[17]  C. Bombardier,et al.  Quality indicators in rheumatoid arthritis care: using measurement to promote quality improvement , 2012, Annals of the rheumatic diseases.

[18]  J. Block,et al.  Rheumatologists' quality of care for lupus: Comparison study between a university and county hospital , 2012, Arthritis care & research.

[19]  J. Yazdany,et al.  Defining quality of care in rheumatology: The American College of Rheumatology white paper on quality measurement , 2011, Arthritis care & research.

[20]  E. Giannini,et al.  Measuring process of arthritis care: A proposed set of quality measures for the process of care in juvenile idiopathic arthritis , 2011, Arthritis care & research.

[21]  C. Deighton,et al.  An update on UK rheumatology consultant workforce provision: the BSR/ARC Workforce Register 2005–07: assessing the impact of recent changes in NHS provision , 2008, Rheumatology.

[22]  J. Smolen,et al.  Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial , 2008, The Lancet.

[23]  J. Tornero Molina,et al.  [Asistance quality standards in rheumatology]. , 2007, Reumatologia clinica.

[24]  G. Kingsley,et al.  Patients' views on the quality of health care for rheumatoid arthritis. , 2006, Rheumatology.

[25]  D. M. van der Heijde,et al.  Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. , 2006, Arthritis and rheumatism.

[26]  D. Khanna,et al.  Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis. , 2006, Seminars in arthritis and rheumatism.

[27]  M. Shipley,et al.  BSR guidelines on standards of care for persons with rheumatoid arthritis. , 2005, Rheumatology.

[28]  M. Dougados,et al.  Role and modalities of information and education in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. , 2005, Joint, bone, spine : revue du rhumatisme.

[29]  D. M. van der Heijde,et al.  Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. , 2004, Arthritis and rheumatism.

[30]  Sally C Morton,et al.  Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. , 2004, Arthritis and rheumatism.

[31]  D Blumenthal,et al.  Quality of health care. Part 4: The origins of the quality-of-care debate. , 1996, The New England journal of medicine.

[32]  A. Donabedian,et al.  The quality of care. How can it be assessed? , 1988, JAMA.

[33]  C. Macieira.  Standard practice aiming clinical excellence in rheumatology. , 2017, Acta reumatologica portuguesa.

[34]  F. Breedveld,et al.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. , 2006, Arthritis and rheumatism.